F 
11.99
+0.59%
Close of 9 Nov 2026, in CNY
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
At a glance
Figures in CNY, from our data supplier.
Net income
CN¥36.3m
FY2016FY2025
Free cash flow
−CN¥91.5m
FY2016FY2025
Shareholders' equity
CN¥65.5m
FY2016FY2025
Income statement
Fiscal years
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Gross profit | CN¥82.0m | CN¥1.7m | CN¥11.9m | CN¥24.6m | CN¥23.0m | CN¥33.6m | CN¥45.4m | CN¥28.9m | CN¥17.9m | CN¥79,834 |
| Operating income | CN¥63.1m | −CN¥210.4m | −CN¥48.9m | CN¥24.9m | −CN¥61.3m | CN¥21.3m | CN¥28.3m | CN¥15.1m | CN¥15.6m | −CN¥7.0m |
| Net income | CN¥36.3m | −CN¥235.6m | −CN¥51.5m | CN¥14.2m | −CN¥50.2m | CN¥21.3m | CN¥19.4m | CN¥20.9m | CN¥19.0m | CN¥2.6m |
| Diluted earnings per share | 0.16 | -1.01 | -0.21 | 0.06 | -0.23 | 0.08 | 0.09 | 0.10 | 0.09 | 0.01 |
Balance sheet
At each fiscal year end
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | CN¥295.9m | CN¥162.0m | CN¥460.5m | CN¥400.0m | CN¥479.5m | CN¥597.6m | CN¥449.0m | CN¥234.1m | CN¥219.4m | CN¥206.2m |
| Cash and short-term investments | — | CN¥29.0m | CN¥38.5m | CN¥60.6m | CN¥60.1m | CN¥152.6m | CN¥67.0m | CN¥95.2m | CN¥192.5m | CN¥183.8m |
| Total liabilities | CN¥183.0m | CN¥165.4m | CN¥224.9m | CN¥79.1m | CN¥174.0m | CN¥340.5m | CN¥216.8m | CN¥50.9m | CN¥57.8m | CN¥63.6m |
| Debt | — | CN¥28.3m | CN¥73.5m | CN¥3.7m | CN¥12.7m | CN¥73.1m | CN¥75.0m | — | CN¥10,000 | CN¥4.9m |
| Shareholders' equity | CN¥65.5m | −CN¥3.4m | CN¥235.6m | CN¥286.5m | CN¥268.5m | CN¥223.1m | CN¥201.9m | CN¥182.5m | CN¥161.6m | CN¥142.6m |
| Shares outstanding | 227m | 233m | 245m | 227m | 221m | 277m | 213m | 217m | 218m | 237m |
Cash flow
Fiscal years
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | CN¥7.9m | −CN¥18.0m | CN¥34.9m | CN¥13.3m | −CN¥85.9m | CN¥94.6m | −CN¥125.1m | −CN¥98.3m | −CN¥781,152 | −CN¥22.0m |
| Capital spending | −CN¥99.4m | −CN¥17.1m | −CN¥27.1m | −CN¥17,848 | −CN¥185,505 | −CN¥1.3m | −CN¥1.9m | −CN¥80,933 | −CN¥686,687 | −CN¥42,010 |
| Free cash flow | −CN¥91.5m | −CN¥35.1m | CN¥7.8m | CN¥13.3m | −CN¥86.1m | CN¥93.3m | −CN¥127.0m | −CN¥98.3m | −CN¥1.5m | −CN¥22.1m |
| Dividends paid | −CN¥1.2m | −CN¥248,757 | −CN¥380,076 | −CN¥34,507 | −CN¥3.4m | −CN¥3.9m | −CN¥1.6m | −CN¥3.4m | −CN¥1.6m | — |
Latest quarters
By quarter end
| Jun 2026 | Mar 2026 | Dec 2025 | Sept 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sept 2024 | |
|---|---|---|---|---|---|---|---|---|
| Gross profit | −CN¥4.6m | CN¥29.4m | CN¥41.3m | CN¥23.6m | CN¥15.9m | CN¥1.2m | CN¥1.4m | −CN¥1.1m |
| Operating income | −CN¥8.4m | CN¥26.6m | CN¥31.8m | CN¥23.7m | CN¥13.3m | −CN¥608,192 | −CN¥135.9m | −CN¥41.7m |
| Net income | −CN¥1.4m | CN¥22.4m | CN¥10.6m | CN¥18.2m | CN¥9.0m | −CN¥1.5m | −CN¥163.5m | −CN¥35.5m |
| Diluted earnings per share | -0.01 | 0.10 | 0.05 | 0.08 | 0.04 | -0.01 | -0.70 | -0.15 |
| Cash from operations | — | — | — | −CN¥12.0m | CN¥23.0m | −CN¥36.0m | — | −CN¥6.0m |
| Capital spending | — | — | −CN¥90.0m | −CN¥1.0m | −CN¥2.0m | −CN¥4.0m | −CN¥3.0m | −CN¥1.0m |
| Free cash flow | — | — | — | −CN¥13.0m | CN¥21.0m | −CN¥40.0m | — | −CN¥7.0m |
| Total assets | CN¥252.3m | CN¥294.4m | CN¥295.9m | CN¥282.8m | CN¥306.7m | CN¥218.6m | CN¥162.0m | CN¥295.1m |
| Cash and short-term investments | — | — | — | CN¥19.5m | CN¥23.4m | CN¥30.0m | CN¥29.0m | CN¥702,258 |
| Debt | — | — | — | CN¥3.5m | — | CN¥4.1m | — | — |
| Shareholders' equity | CN¥86.4m | CN¥87.8m | CN¥65.5m | CN¥22.2m | CN¥4.0m | −CN¥5.0m | −CN¥3.4m | CN¥159.2m |
Financial ratios
Data as of 30 Oct 2026
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | |
|---|---|---|---|---|---|---|---|
| Gross margin | 4.7% | 0.4% | 1.5% | 1.3% | 1.4% | 1.3% | — |
| Operating margin | 3.3% | -51.3% | -6.0% | 1.4% | -3.6% | 1.4% | — |
| Net margin | 2.1% | -57.4% | -6.3% | 0.8% | -3.1% | 0.8% | — |
| Return on equity | 55.5% | 6848.2% | -21.9% | 5.0% | -18.7% | 9.6% | — |
| Return on assets | 12.3% | -145.4% | -11.2% | 3.6% | -10.5% | 3.6% | — |
| Free cash flow yield | 4.0% | -0.0% | 2.1% | 0.5% | -3.3% | 2.9% | — |
| Revenue growth | 325.0% | -49.9% | -55.7% | 14.6% | -39.7% | 31.0% | — |
| Earnings growth | -115.4% | 357.4% | -462.0% | -128.3% | -335.4% | 10.0% | — |
| Current ratio | 0.87x | 0.41x | 1.83x | 4.35x | 2.45x | 1.72x | — |
| Debt to equity | — | -1.24x | 0.06x | 0.01x | 0.02x | 0.33x | 0.37x |
| Equity ratio | 22.1% | -2.1% | 51.2% | 71.6% | 56.0% | 37.3% | — |
| Interest coverage | 24.42x | -79.22x | -24.42x | 97.06x | -15.67x | 9.21x | — |
| Buybacks as a share of market value | 2.6% | 4.7% | -7.7% | -2.9% | 20.2% | -29.8% | — |
Growth per year
Compound annual rate
| 3 years | 5 years | 10 years | |
|---|---|---|---|
| Revenue | -1.9% | -8.2% | 63.0% |
| Operating income | 36.3% | 24.2% | — |
| Net income | 36.7% | 11.2% | -0.6% |
Average margins
Over each period
| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| Gross margin | 3.9% | 2.5% | 1.9% | 2.0% |
| Operating margin | -6.8% | -3.6% | -2.3% | -1.2% |
| Net margin | -9.3% | -4.9% | -2.9% | -1.2% |
Valuation history
At each fiscal year end
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Price to earnings | 53.1 | -6.2 | -49.5 | 225.1 | -71.8 | 200.7 | 102.0 | 90.8 | 127.5 | — |
| Price to sales | 1.1 | 3.6 | 3.1 | 1.7 | 2.2 | 1.6 | 1.0 | 1.0 | 7.0 | 104.9 |
Dividends and splits
Per share, in the currency the company pays
Paid for 0 years. Last went ex-dividend on 22 Dec 1999.
| FY1999 | |
|---|---|
| Paid in the year | 0.023 |
- 6-for-5 split · 11 Jun 2021
- 7-for-5 split · 1 Jun 2020
- 1-to-1 reverse split · 22 May 2007
- 1-to-1 reverse split · 17 Jul 2006
- 8-for-5 split · 18 Mar 1998
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.